EA
EGRX

Emerald Acquisition’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Emerald Acquisition’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.78M Buy
25,418
+3,798
+18% +$210K ﹤0.01% 1819
2016
Q2 		$839K Buy
+21,620
New +$900K ﹤0.01% 2253

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Emerald Acquisition's EGRX Position: Q3 2016 in Review

Emerald Acquisition increased its Eagle Pharmaceuticals, Inc. (EGRX) stake by 18% in Q3 2016, buying an estimated $210K and bringing the position to 25,418 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

Emerald Acquisition first reported a position in EGRX in Q2 2016 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold EGRX as of Q3 2016.

  • Emerald Acquisition held 25,418 shares of Eagle Pharmaceuticals, Inc. worth $1.78M as of Q3 2016.
  • Emerald Acquisition bought 3,798 Eagle Pharmaceuticals, Inc. shares in Q3 2016, an estimated $210K.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1819 holding.
  • Emerald Acquisition first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.